Clinuvel Pharmaceuticals Limited (ASX:CUV)

Clinuvel Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 15, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	536	770	883	734	1,517	1,267
Market Cap Growth	-24.90%	-12.87%	20.40%	-51.63%	19.69%	-23.14%
Enterprise Value	338	596	744	636	1,445	1,210
Last Close Price	10.71	15.32	17.77	14.73	30.43	25.39
PE Ratio	13.92	21.60	28.87	35.14	61.34	84.20
PS Ratio	5.88	8.73	11.28	11.16	31.39	38.92
PB Ratio	2.46	3.79	5.37	5.84	15.36	17.59
P/TBV Ratio	2.47	3.80	5.37	5.85	15.39	17.63
P/FCF Ratio	22.80	24.46	24.62	18.61	82.41	95.30
P/OCF Ratio	22.48	20.77	23.93	18.40	78.75	89.33
EV/Sales Ratio	3.71	6.76	9.50	9.68	29.91	37.16
EV/EBITDA Ratio	6.49	12.09	16.71	17.68	49.73	97.48
EV/EBIT Ratio	6.64	12.28	16.86	17.89	50.60	98.79
EV/FCF Ratio	14.39	18.95	20.73	16.13	78.52	91.00
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.03	0.04	0.10
Debt / FCF Ratio	0.03	0.03	0.03	0.03	0.07	0.10
Asset Turnover	0.41	0.42	0.46	0.52	0.51	0.45
Inventory Turnover	0.76	0.77	1.33	3.69	1.87	4.26
Quick Ratio	16.37	8.33	7.02	10.03	11.35	8.88
Current Ratio	17.37	8.81	7.44	10.24	11.81	9.10
Return on Equity (ROE)	19.59%	19.39%	21.09%	18.62%	28.95%	23.29%
Return on Assets (ROA)	14.22%	14.29%	16.34%	17.60%	18.78%	10.64%
Return on Capital (ROIC)	16.01%	16.43%	18.86%	19.59%	20.59%	11.69%
Return on Capital Employed (ROCE)	22.80%	23.60%	26.20%	27.30%	28.60%	16.70%
Earnings Yield	7.24%	4.63%	3.46%	2.84%	1.63%	1.19%
FCF Yield	4.39%	4.09%	4.06%	5.38%	1.21%	1.05%
Dividend Yield	0.46%	0.33%	0.28%	0.27%	0.08%	0.10%
Payout Ratio	6.46%	6.93%	6.46%	5.92%	5.00%	8.13%
Buyback Yield / Dilution	2.63%	1.52%	-0.08%	-1.26%	-1.33%	-1.73%
Total Shareholder Return	3.09%	1.85%	0.21%	-0.99%	-1.25%	-1.63%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.